Compensation expense for the Company’s share-based plans was as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | October 3, 2026 | | September 27, 2025 | | October 3, 2026 | | September 27, 2025 | | Share-based compensation expense included in: | | | | | | | | | Costs of sales | $ | 22 | | | $ | 14 | | | $ | 64 | | | $ | 42 | | | Selling, general and administrative expenses | 56 | | | 41 | | | 168 | | | 116 | | | Research and development expenditures | 25 | | | 18 | | | 75 | | | 55 | | | Share-based compensation expense included in Operating earnings | 103 | | | 73 | | | 307 | | | 213 | | | Tax benefit | (17) | | | (16) | | | (52) | | | (45) | | | Share-based compensation expense, net of tax | $ | 86 | | | $ | 57 | | | $ | 255 | | | $ | 168 | | | Decrease in basic earnings per share | $ | (0.52) | | | $ | (0.34) | | | $ | (1.54) | | | $ | (1.01) | | | Decrease in diluted earnings per share | $ | (0.51) | | | $ | (0.34) | | | $ | (1.52) | | | $ | (0.99) | | | | | | | | | |
|